1/17
11:21 am
aqst
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Low
Report
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
1/16
07:24 pm
aqst
Jim Cramer: The whole Aquestive situation seems very ambiguous [CNBC]
Low
Report
Jim Cramer: The whole Aquestive situation seems very ambiguous [CNBC]
1/15
10:00 am
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
1/14
10:22 am
aqst
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Low
Report
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
1/13
04:42 pm
aqst
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
1/12
08:32 pm
aqst
Aquestive Therapeutics: Anaphylm Will Probably Survive This Regulatory Hurdle [Seeking Alpha]
Medium
Report
Aquestive Therapeutics: Anaphylm Will Probably Survive This Regulatory Hurdle [Seeking Alpha]
1/11
12:45 pm
aqst
Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies [Yahoo! Finance]
High
Report
Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies [Yahoo! Finance]
1/10
07:02 pm
aqst
Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next [Yahoo! Finance]
High
Report
Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next [Yahoo! Finance]
1/9
02:11 pm
aqst
INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLC
Low
Report
INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLC
1/9
11:49 am
aqst
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
Medium
Report
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
1/9
10:06 am
aqst
BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies Deficiencies; Investors Should Contact Block & Leviton To Potentially Recover Losses
Low
Report
BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies Deficiencies; Investors Should Contact Block & Leviton To Potentially Recover Losses
1/9
07:41 am
aqst
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update [Yahoo! Finance]
Medium
Report
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update [Yahoo! Finance]
1/9
07:00 am
aqst
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
High
Report
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
1/9
04:31 am
aqst
Aquestive Therapeutics: Looking For The PDUFA Run-Up [Seeking Alpha]
High
Report
Aquestive Therapeutics: Looking For The PDUFA Run-Up [Seeking Alpha]
11/24
07:00 am
aqst
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/13
12:36 pm
aqst
Jim Cramer on Aquestive Therapeutics: “I Think It's a Very Interesting Spec” [Yahoo! Finance]
Low
Report
Jim Cramer on Aquestive Therapeutics: “I Think It's a Very Interesting Spec” [Yahoo! Finance]
11/9
08:43 am
aqst
Looking at the Narrative for Aquestive Therapeutics After Patent Wins and FDA Milestones [Yahoo! Finance]
Medium
Report
Looking at the Narrative for Aquestive Therapeutics After Patent Wins and FDA Milestones [Yahoo! Finance]
11/8
07:58 am
aqst
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.10 [Yahoo! Finance]
Medium
Report
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.10 [Yahoo! Finance]
11/7
08:07 am
aqst
Aquestive Therapeutics (NASDAQ:AQST) had its price target raised by analysts at Piper Sandler from $5.00 to $8.00. They now have an "overweight" rating on the stock.
Low
Report
Aquestive Therapeutics (NASDAQ:AQST) had its price target raised by analysts at Piper Sandler from $5.00 to $8.00. They now have an "overweight" rating on the stock.
11/5
04:01 pm
aqst
Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Low
Report
Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
11/4
07:00 am
aqst
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
Medium
Report
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
11/3
07:00 am
aqst
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
Medium
Report
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
10/30
07:00 am
aqst
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
Low
Report
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
10/27
07:00 am
aqst
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
Low
Report
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
10/24
04:22 pm
aqst
What Recent Patent Extensions and FDA Progress Mean for Aquestive Therapeutics's Valuation [Yahoo! Finance]
Low
Report
What Recent Patent Extensions and FDA Progress Mean for Aquestive Therapeutics's Valuation [Yahoo! Finance]